Location
Suwanee, GA
Start Date
17-4-2026 12:00 PM
End Date
17-4-2026 1:00 PM
Description
Introduction: Utilization review processes such as prior authorizations are commonly used by health insurers to manage healthcare utilization in the United States. Although designed to promote cost-effective care and evidence-based treatment, concerns have been raised that these processes may contribute to delays in treatment and increase clinicians' administrative responsibilities. In Georgia, state statutes do not explicitly authorize insurers to make clinical decisions, yet the legal framework provides limited statutory guidance on the extent to which insurers may influence or delay physician-directed care. In contrast, several states have adopted more explicit statutory provisions governing utilization review practices, including requirements for transparency, physician involvement in review processes, and timelines intended to minimize delays in patient care. We hypothesize that states with stronger statutory protections for physician clinical judgment and clearer oversight of insurance utilization review processes will demonstrate improved performance on delay-sensitive patient safety metrics.
Objective: To evaluate whether states with stronger statutory oversight of utilization review processes demonstrate improved delay-sensitive health system outcomes, including 30-day readmissions, preventable hospitalizations, and avoidable emergency department utilization.
Methods: This study employed a policy-informed literature review combined with analysis of publicly available national datasets. Healthcare utilization and outcome metrics were obtained from Centers for Medicare & Medicaid Services (CMS) Care Compare data for 30-day hospital readmission measures and the Agency for Healthcare Research and Quality (AHRQ) Prevention Quality Indicators (PQIs) for preventable hospitalizations. Emergency department utilization data were derived from the Healthcare Cost and Utilization Project (HCUP), including the State Emergency Department Databases (SEDD) and the Nationwide Emergency Department Sample (NEDS), to assess patterns of potentially avoidable emergency department use. Prior authorization practices and denial patterns were examined using American Medical Association (AMA) survey data and CMS Medicare Advantage prior authorization and appeals datasets. Policy structures were compared across selected states, including Texas, New York, Oregon, and Georgia, focusing on statutory requirements governing utilization review processes, physician peer-review provisions, and insurer accountability mechanisms.
Results: Existing literature and administrative datasets indicate that prior authorization requirements may contribute to delays in patient care and increased administrative burdens for clinicians. AMA physician survey data reports that many physicians experience treatment delays due to prior authorization requirements. System-level outcome measures, including 30-day hospital readmission rates, prevent hospitalizations, and avoidable emergency department visits, are widely recognized indicators of delayed or poorly coordinated care. Some states have adopted more explicit statutory frameworks governing utilization review and prior authorization practices.
Discussion and Conclusion:
These findings suggest that stronger statutory oversight of insurer utilization review processes may be associated with improved performance on delay-sensitive patient safety metrics. Federal legislation, such as the Employee Retirement Income Security Act of 1974 (ERISA), may limit the effectiveness of state-level reforms intended to expand insurer accountability. Policy frameworks requiring qualified physician peer review and clearer accountability for coverage determinations may help reduce delays in care and improve care coordination. States considering reforms may benefit from policies that reinforce physician clinical judgment in medical-necessity determinations while promoting transparency and accountability in insurer decision-making.
Embargo Period
5-29-2026
Included in
Utilization Review Oversight and Patient Outcomes: A Comparative Analysis of Utilization Review Oversight Across U.S. States
Suwanee, GA
Introduction: Utilization review processes such as prior authorizations are commonly used by health insurers to manage healthcare utilization in the United States. Although designed to promote cost-effective care and evidence-based treatment, concerns have been raised that these processes may contribute to delays in treatment and increase clinicians' administrative responsibilities. In Georgia, state statutes do not explicitly authorize insurers to make clinical decisions, yet the legal framework provides limited statutory guidance on the extent to which insurers may influence or delay physician-directed care. In contrast, several states have adopted more explicit statutory provisions governing utilization review practices, including requirements for transparency, physician involvement in review processes, and timelines intended to minimize delays in patient care. We hypothesize that states with stronger statutory protections for physician clinical judgment and clearer oversight of insurance utilization review processes will demonstrate improved performance on delay-sensitive patient safety metrics.
Objective: To evaluate whether states with stronger statutory oversight of utilization review processes demonstrate improved delay-sensitive health system outcomes, including 30-day readmissions, preventable hospitalizations, and avoidable emergency department utilization.
Methods: This study employed a policy-informed literature review combined with analysis of publicly available national datasets. Healthcare utilization and outcome metrics were obtained from Centers for Medicare & Medicaid Services (CMS) Care Compare data for 30-day hospital readmission measures and the Agency for Healthcare Research and Quality (AHRQ) Prevention Quality Indicators (PQIs) for preventable hospitalizations. Emergency department utilization data were derived from the Healthcare Cost and Utilization Project (HCUP), including the State Emergency Department Databases (SEDD) and the Nationwide Emergency Department Sample (NEDS), to assess patterns of potentially avoidable emergency department use. Prior authorization practices and denial patterns were examined using American Medical Association (AMA) survey data and CMS Medicare Advantage prior authorization and appeals datasets. Policy structures were compared across selected states, including Texas, New York, Oregon, and Georgia, focusing on statutory requirements governing utilization review processes, physician peer-review provisions, and insurer accountability mechanisms.
Results: Existing literature and administrative datasets indicate that prior authorization requirements may contribute to delays in patient care and increased administrative burdens for clinicians. AMA physician survey data reports that many physicians experience treatment delays due to prior authorization requirements. System-level outcome measures, including 30-day hospital readmission rates, prevent hospitalizations, and avoidable emergency department visits, are widely recognized indicators of delayed or poorly coordinated care. Some states have adopted more explicit statutory frameworks governing utilization review and prior authorization practices.
Discussion and Conclusion:
These findings suggest that stronger statutory oversight of insurer utilization review processes may be associated with improved performance on delay-sensitive patient safety metrics. Federal legislation, such as the Employee Retirement Income Security Act of 1974 (ERISA), may limit the effectiveness of state-level reforms intended to expand insurer accountability. Policy frameworks requiring qualified physician peer review and clearer accountability for coverage determinations may help reduce delays in care and improve care coordination. States considering reforms may benefit from policies that reinforce physician clinical judgment in medical-necessity determinations while promoting transparency and accountability in insurer decision-making.